This page lists feature articles on COVID-19 relevant to people working at St Vincent's Health Australia.
All articles listed are open access unless stated otherwise.
Victorian Specialist Immunisation Services (VicSIS) – bolstering adult clinics for COVID-19 vaccines. AUS
Human Vaccines and Immunotherapeutics:2022: April 26 Full text
Pathophysiology and Long Covid
Clinical characteristics with inflammation profiling of long COVID and association with 1-year recovery following hospitalisation in the UK: a prospective observational study.
Lancet Respiratory Medicine:2022: April 23 Full text
Post-acute sequelae of SARS-CoV-2 infection. Osteonecrosis must not be overlooked.
International Journal of Infectious Diseases:2022: April 21 Full text
COVID-19 patients require multi-disciplinary rehabilitation approaches to address persisting symptom profiles and restore pre-COVID quality of life.
Expert Review of Respiratory Medicine:2022: April 18 Full text
30-day mortality following COVID-19 and influenza hospitalization Among US veterans aged 65 and older.
Journal of the American Geriatrics Society: 2022: April 26 Full text
Impact of population mixing between vaccinated and unvaccinated subpopulations on infectious disease dynamics: implications for SARS-CoV-2 transmission.
CMJA:2022:194(1):E573-80 Full text
Reducing the particles generated by flushing institutional toilets.
Journal of Occupational and Environmental Hygiene:2022: April 19 Full text
Public health impact of covid-19 vaccines in the US: observational study.
BMJ:2022: April 27 Full text
The performance of wearable sensors in the detection of SARS-CoV-2 infection: a systematic review.
Lancet Digital Health:2022: April 20 Full text
Durability of BNT162b2 vaccine against hospital and emergency department admissions due to the omicron and delta variants in a large health system in the USA: a test-negative case–control study.
Lancet Respiratory Medicine:2022: April 22 Full text
Effectiveness of a second BNT162b2 booster vaccine against hospitalization and death from COVID-19 in adults aged over 60 years.
Nature Medicine:2022: April 25 Full text
Safety and immunogenicity of the Pfizer/BioNTech SARS-CoV-2 mRNA third booster vaccine dose against the SARS-CoV-2 BA.1 and BA.2 Omicron variants.
Med:2022: April 26 Full text
Neutralization of SARS-CoV-2 Omicron sub-lineages BA.1, BA.1.1, and BA.2.
Cell Host and Microbe:2022: April 24 Full text
Psychological symptoms associated with self-reported events of COVID-19 contact, symptoms, or diagnosis: a large community-based survey among adults in Quebec, Canada.
Canadian Journal of Public Health:2022: April 18 Full text